Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy

por Saeki, Issei, Yamasaki, Takahiro, Yamauchi, Yurika, Kawaoka, Tomokazu, Uchikawa, Shinsuke, Hiramatsu, Akira, Aikata, Hiroshi, Kobayashi, Kazufumi, Kondo, Takayuki, Ogasawara, Sadahisa, Chiba, Tetsuhiro, Kawano, Reo, Chayama, Kazuaki, Kato, Naoya, Takami, Taro
Publicado 2023

Skeletal Muscle Volume Is an Independent Predictor of Survival after Sorafenib Treatment Failure for Hepatocellular Carcinoma

por Saeki, Issei, Yamasaki, Takahiro, Yamauchi, Yurika, Takami, Taro, Kawaoka, Tomokazu, Uchikawa, Shinsuke, Hiramatsu, Akira, Aikata, Hiroshi, Kawano, Reo, Kobayashi, Kazufumi, Kondo, Takayuki, Ogasawara, Sadahisa, Chiba, Tetsuhiro, Chayama, Kazuaki, Kato, Naoya, Sakaida, Isao
Publicado 2021

Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment

por Yamasaki, Takahiro, Saeki, Issei, Yamauchi, Yurika, Matsumoto, Toshihiko, Suehiro, Yutaka, Kawaoka, Tomokazu, Uchikawa, Shinsuke, Hiramatsu, Akira, Aikata, Hiroshi, Kobayashi, Kazufumi, Kondo, Takayuki, Ogasawara, Sadahisa, Chiba, Tetsuhiro, Takami, Taro, Chayama, Kazuaki, Kato, Naoya, Sakaida, Isao
Publicado 2022